Clinical Trials for Ellipses Pharma

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Ellipses Pharma

Clinical Trials (4)

NCT07030478
A Study to Evaluate the Safety and Tolerability of EP0089
PHASE1/PHASE2Not yet recruiting
190 participants
Started: Sep 30, 2025 · Completed: Jun 30, 2029
2 conditions1 sponsor0 locations
NCT05573126
Phase 1/2 Study to Evaluate Vosilasarm (EP0062) as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
PHASE1/PHASE2Recruiting
60 participants
Started: Jan 11, 2023 · Completed: Nov 30, 2026
3 conditions1 sponsor14 locations
NCT05443126
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
PHASE1/PHASE2Recruiting
265 participants
Started: Sep 30, 2022 · Completed: Jun 30, 2027
2 conditions1 sponsor36 locations
NCT04581512
Study to Evaluate the Safety and Tolerability of EP0042
PHASE1/PHASE2Recruiting
70 participants
Started: Nov 2, 2020 · Completed: Dec 31, 2026
3 conditions1 sponsor6 locations